Immunome, Inc. · NASDAQ:IMNM
Rosett Max sold 65,000 Immunome, Inc. shares (Form 4)
Traded Apr 2, 2026 · Filed Apr 3, 2026
On Apr 2, 2026, Rosett Max (Chief Financial Officer) sold 65,000 Immunome, Inc. shares at an average US$21.92 for US$1.42M under a trading plan, leaving 54,037 shares. Filed Apr 3, 2026 (Form 4).
- Sold
- 65,000 shares
- Price
- US$21.92 average (US$21.91 to US$22.48)
- Value
- US$1.42M
- Holding after
- 54,037 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 2, 2026 | Common Stock | Option exercise | 31,848 | US$1.05 | 79,324 | Direct |
| Apr 2, 2026 | Common Stock | Option exercise | 39,713 | US$1.35 | 119,037 | Direct |
| Apr 2, 2026 | Common Stock | Sale | 63,656 | US$21.91 | 55,381 | Direct |
| Apr 2, 2026 | Common Stock | Sale | 1,344 | US$22.48 | 54,037 | Direct |
Source
Related
- Immunome, Inc.
- Rosett Max
- Immunome, Inc. shareholders
- Form 4 · Rosett Max · Jul 27, 2026
- Form 4 · Rosett Max · Jun 17, 2026
- Form 4 · Higgins Jack · Sep 15, 2026
- Schedule 13G/A · Sirenia Capital Management LP · Aug 14, 2026
- Schedule 13G/A · T. Rowe Price Investment Management, Inc. · Aug 14, 2026
- Form 4 · Barchas Isaac · Aug 12, 2026
- Form 4 · Barchas Isaac · Aug 10, 2026